StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Alnylam Pharmaceuticals (ALNY) PT Lowered to $175 at BMO Capital
February 11, 2022 7:21 AM
BMO Capital analyst Gary Nachman lowered the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $175.00 (from $180.00) while maintaining ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS View
Analyst PT Change
Next Articles
Alnylam (ALNY) PT Raised to $205 at Oppenheimer, Shares Look Attractive Into 2022 Business and Catalysts
February 11, 2022 5:13 AM
Form 10-K ALNYLAM PHARMACEUTICALS, For: Dec 31
February 10, 2022 8:40 AM
Form 8-K ALNYLAM PHARMACEUTICALS, For: Feb 10
February 10, 2022 8:10 AM
Alnylam Pharma (ALNY) Misses Q4 EPS by 13c
February 10, 2022 8:07 AM
Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Period Activity
February 10, 2022 8:00 AM
